Free Trial

Immatics (IMTXW) Financials

Immatics logo
$0.01 0.00 (-11.54%)
As of 04/17/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Annual Income Statements for Immatics

Annual Income Statements for Immatics

This table shows Immatics' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
-36 -35 -258 -106 30 -105 16
Consolidated Net Income / (Loss)
-37 -36 -259 -106 30 -105 16
Net Income / (Loss) Continuing Operations
-37 -36 -259 -106 30 -105 16
Total Pre-Tax Income
-37 -36 -259 -106 45 -107 22
Total Operating Income
-39 -37 -85 -98 32 -113 -40
Total Gross Profit
4.31 21 38 39 185 60 161
Total Revenue
4.31 21 38 39 185 60 161
Operating Revenue
4.31 21 38 39 185 60 161
Total Cost of Revenue
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses
44 58 124 137 153 172 201
Selling, General & Admin Expense
8.77 13 42 38 39 42 48
Research & Development Expense
39 45 82 99 114 131 153
Other Operating Expenses / (Income)
-3.96 -0.43 - -0.37 -0.03 -1.26 -0.08
Total Other Income / (Expense), net
2.35 0.59 -174 -7.97 13 5.23 62
Other Income / (Expense), net
0.00 0.00 13 -7.97 13 5.23 62
Income Tax Expense
0.00 0.00 0.00 0.00 15 -2.59 6.34
Basic Earnings per Share
($0.95) ($0.95) ($4.40) ($1.48) $0.44 ($1.31) $0.14
Weighted Average Basic Shares Outstanding
33.09M 33.09M 48.00M 62.91M 76.67M 84.66M 121.55M
Diluted Earnings per Share
($0.95) ($0.95) ($4.40) ($1.48) $0.43 ($1.31) $0.14
Weighted Average Diluted Shares Outstanding
33.09M 33.09M 48.00M 62.91M 76.67M 84.66M 121.55M
Weighted Average Basic & Diluted Shares Outstanding
33.09M 33.09M 48.00M 62.91M 76.67M 84.66M 121.55M

Quarterly Income Statements for Immatics

No quarterly income statements for Immatics are available.


Annual Cash Flow Statements for Immatics

This table details how cash moves in and out of Immatics' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
35 72 136 -90 15 -0.97 -137
Net Cash From Operating Activities
24 80 -99 -96 107 -0.97 -137
Net Cash From Continuing Operating Activities
24 80 -71 -57 100 -0.97 -137
Net Income / (Loss) Continuing Operations
-37 -36 -259 -106 75 -105 16
Consolidated Net Income / (Loss)
-37 -36 -259 -106 75 -105 16
Depreciation Expense
2.49 4.33 5.40 5.95 7.45 8.00 13
Non-Cash Adjustments To Reconcile Net Income
1.38 2.36 185 43 26 0.60 0.00
Changes in Operating Assets and Liabilities, net
57 109 -1.68 -0.35 -8.10 95 -166
Net Cash From Investing Activities
-15 -5.68 -19 8.48 -224 0.00 0.00
Net Cash From Continuing Investing Activities
-15 -5.68 -19 8.48 -224 0.00 0.00
Net Cash From Financing Activities
27 -2.09 254 -2.96 132 0.00 0.00
Net Cash From Continuing Financing Activities
27 -2.09 264 -2.96 141 0.00 0.00
Cash Interest Received
- - - - - 11 16

Quarterly Cash Flow Statements for Immatics

No quarterly cash flow statements for Immatics are available.


Annual Balance Sheets for Immatics

This table presents Immatics' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Total Assets
151 311 198 436 564 721
Total Current Assets
139 292 172 403 497 652
Cash & Equivalents
116 254 151 159 242 245
Accounts Receivable
1.07 1.53 0.77 1.19 4.53 6.06
Other Current Assets
4.12 7.04 7.25 15 21 20
Other Current Nonoperating Assets
18 30 - 229 229 381
Plant, Property, & Equipment, net
5.30 9.61 12 14 48 52
Plant, Property & Equipment, gross
5.30 9.61 12 14 48 52
Total Noncurrent Assets
6.24 9.51 27 18 19 17
Intangible Assets
1.13 1.12 1.49 1.75 1.68 1.69
Other Noncurrent Operating Assets
5.11 8.40 26 17 17 15
Total Liabilities & Shareholders' Equity
151 311 198 436 564 721
Total Liabilities
197 204 170 219 323 124
Total Current Liabilities
78 95 73 114 173 70
Accounts Payable
7.95 12 13 14 28 21
Other Current Liabilities
70 82 2.89 82 124 47
Total Noncurrent Liabilities
119 110 97 105 150 55
Capital Lease Obligations
2.05 5.26 11 13 14 14
Noncurrent Deferred & Payable Income Tax Liabilities
- - - 10 8.26 6.01
Other Noncurrent Operating Liabilities
117 104 32 99 149 35
Total Equity & Noncontrolling Interests
-47 107 27 218 241 595
Total Preferred & Common Equity
-46 107 27 218 241 595
Preferred Stock
214 658 - 764 911 1,203
Total Common Equity
-261 -551 27 -546 -670 -608
Common Stock
1.31 0.77 0.71 0.82 0.94 1.26
Retained Earnings
-262 -543 -609 -546 -669 -610
Other Equity Adjustments
-0.86 -9.11 635 -1.58 -1.81 1.07

Quarterly Balance Sheets for Immatics

No quarterly balance sheets for Immatics are available.


Annual Metrics and Ratios for Immatics

This table displays calculated financial ratios and metrics derived from Immatics' official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - -
Revenue Growth
0.00% 379.85% 84.40% 3.05% 369.93% -67.69% 170.05%
EBITDA Growth
0.00% 11.31% -102.83% -50.20% 152.59% -289.40% 135.00%
EBIT Growth
0.00% 5.92% -93.72% -47.19% 142.57% -338.59% 120.59%
NOPAT Growth
0.00% 5.92% -129.87% -14.68% 130.89% -472.99% 63.82%
Net Income Growth
0.00% 1.54% -609.80% 59.18% 128.06% -453.28% 115.04%
EPS Growth
0.00% 0.00% -363.16% 66.36% 128.91% -405.05% 111.10%
Operating Cash Flow Growth
0.00% 236.43% -223.78% 2.70% 211.68% -100.90% -14,081.33%
Free Cash Flow Firm Growth
0.00% 0.00% -143.47% -93.35% 151.45% -129.25% -1,096.21%
Invested Capital Growth
0.00% 0.00% 3.59% 34.57% -39.71% -38.02% 93.05%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - -
Gross Margin
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin
-854.99% -158.03% -173.83% -253.36% 28.35% -166.23% 21.54%
Operating Margin
-912.71% -178.94% -223.07% -248.24% 17.33% -188.39% -24.78%
EBIT Margin
-912.71% -178.94% -187.99% -268.49% 24.32% -179.63% 13.70%
Profit (Net Income) Margin
-858.22% -176.09% -677.83% -268.49% 16.03% -175.29% 9.77%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 65.90% 97.58% 71.29%
Interest Burden Percent
94.03% 98.41% 360.57% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 34.10% 0.00% 28.71%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% 77.62% -865.79% -157.68% 24.21% -45.69% 3.77%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% -24.59% -31.08% -41.53% 14.19% -21.45% 3.44%
Return on Assets (ROA)
0.00% -24.19% -112.08% -41.53% 9.35% -20.93% 2.45%
Return on Common Equity (ROCE)
0.00% 431.72% 11,768.56% 616.77% -51.37% 121.28% -5.76%
Return on Equity Simple (ROE_SIMPLE)
0.00% 79.56% -242.42% -387.88% 13.62% -43.49% 2.65%
Net Operating Profit after Tax (NOPAT)
-28 -26 -60 -68 21 -79 -28
NOPAT Margin
-638.89% -125.26% -156.15% -173.76% 11.42% -131.87% -17.67%
Net Nonoperating Expense Percent (NNEP)
0.00% -16.09% -97.42% -17.85% 3.32% -6.24% 8.29%
Return On Investment Capital (ROIC_SIMPLE)
- - - - 9.15% -30.90% -4.68%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
203.34% 63.72% 109.38% 97.25% 20.90% 70.74% 29.81%
R&D to Revenue
901.09% 217.31% 214.65% 251.92% 61.78% 219.76% 95.02%
Operating Expenses to Revenue
1,012.71% 278.94% 324.04% 348.24% 82.67% 288.39% 124.78%
Earnings before Interest and Taxes (EBIT)
-39 -37 -72 -106 45 -107 22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-37 -33 -66 -100 52 -99 35
Valuation Ratios
- - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 31.04 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 32.84 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.00 0.00 21.49 2.96 13.52 3.73
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 18.49 0.00 38.21
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 5.41% 0.00% 2.62%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 17.95 6.31 24.95 9.76
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 22.25 0.00 45.28
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 25.94 0.00 71.22
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 55.24 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 10.89 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 17.77 0.00 0.00
Leverage & Solvency
- - - - - - -
Debt to Equity
0.00 -0.04 0.05 0.41 0.06 0.06 0.02
Long-Term Debt to Equity
0.00 -0.04 0.05 0.41 0.06 0.06 0.02
Financial Leverage
0.00 2.78 -6.84 -3.12 -2.10 -1.81 -1.28
Leverage Ratio
0.00 -3.21 7.72 3.80 2.59 2.18 1.54
Compound Leverage Factor
0.00 -3.16 27.85 3.80 2.59 2.18 1.54
Debt to Total Capital
0.00% -4.55% 4.70% 29.05% 5.75% 5.55% 2.27%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% -4.55% 4.70% 29.05% 5.75% 5.55% 2.27%
Preferred Equity to Total Capital
0.00% -476.98% 587.50% 0.00% 331.01% 357.25% 197.58%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 581.53% -492.19% 70.95% -236.76% -262.81% -99.85%
Debt to EBITDA
0.00 -0.06 -0.08 -0.11 0.25 -0.14 0.40
Net Debt to EBITDA
0.00 3.48 3.74 1.40 -2.78 2.29 -6.65
Long-Term Debt to EBITDA
0.00 -0.06 -0.08 -0.11 0.25 -0.14 0.40
Debt to NOPAT
0.00 -0.08 -0.09 -0.16 0.63 -0.18 -0.49
Net Debt to NOPAT
0.00 4.39 4.16 2.04 -6.90 2.89 8.11
Long-Term Debt to NOPAT
0.00 -0.08 -0.09 -0.16 0.63 -0.18 -0.49
Altman Z-Score
0.00 0.00 0.00 -2.30 1.31 0.00 3.03
Noncontrolling Interest Sharing Ratio
0.00% -456.21% 1,459.28% 491.15% 312.13% 365.42% 252.89%
Liquidity Ratios
- - - - - - -
Current Ratio
0.00 1.79 3.08 2.36 3.54 2.87 9.26
Quick Ratio
0.00 1.51 2.69 2.07 1.41 1.42 3.57
Cash Flow Metrics
- - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 152 -66 -128 66 -19 -230
Operating Cash Flow to CapEx
6,174.33% 3,468.57% -1,087.55% -1,659.73% 1,624.71% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 512.42 -0.35 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
128.47 268.81 -0.53 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
126.39 261.06 -0.58 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - -
Asset Turnover
0.00 0.14 0.17 0.15 0.58 0.12 0.25
Accounts Receivable Turnover
0.00 19.28 29.36 34.23 188.63 20.90 30.46
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 3.91 5.12 3.66 14.07 1.90 3.21
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 18.93 12.43 10.66 1.94 17.47 11.98
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 18.93 12.43 10.66 1.94 17.47 11.98
Capital & Investment Metrics
- - - - - - -
Invested Capital
0.00 -178 -171 -112 -157 -216 -15
Invested Capital Turnover
0.00 -0.23 -0.22 -0.28 -1.38 -0.32 -1.39
Increase / (Decrease) in Invested Capital
0.00 -178 6.38 59 -45 -60 201
Enterprise Value (EV)
0.00 0.00 0.00 706 1,167 1,490 1,574
Market Capitalization
0.00 0.00 0.00 845 548 807 602
Book Value per Share
$0.00 ($7.89) ($11.49) $0.43 ($8.68) ($8.74) ($7.18)
Tangible Book Value per Share
$0.00 ($7.93) ($11.51) $0.41 ($8.71) ($8.76) ($7.20)
Total Capital
0.00 -45 112 38 231 255 609
Total Debt
0.00 2.05 5.26 11 13 14 14
Total Long-Term Debt
0.00 2.05 5.26 11 13 14 14
Net Debt
0.00 -114 -248 -139 -146 -228 -231
Capital Expenditures (CapEx)
0.38 2.30 9.06 5.78 6.59 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -55 -56 -51 131 82 336
Debt-free Net Working Capital (DFNWC)
0.00 61 197 99 290 324 581
Net Working Capital (NWC)
0.00 61 197 99 290 324 581
Net Nonoperating Expense (NNE)
9.46 11 199 37 -8.52 26 -44
Net Nonoperating Obligations (NNO)
0.00 -131 -278 -139 -374 -457 -610
Total Depreciation and Amortization (D&A)
2.49 4.33 5.40 5.95 7.45 8.00 13
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -263.69% -147.24% -130.50% 70.70% 137.69% 208.44%
Debt-free Net Working Capital to Revenue
0.00% 296.51% 516.79% 252.08% 156.63% 542.29% 360.36%
Net Working Capital to Revenue
0.00% 296.51% 516.79% 252.08% 156.63% 542.29% 360.36%
Earnings Adjustments
- - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 ($1.48) $0.56 ($1.20) $0.14
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 62.93M 76.67M 84.66M 121.55M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 ($1.48) $0.55 ($1.20) $0.14
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 62.93M 76.67M 84.66M 121.55M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 ($1.48) $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 62.91M 76.67M 84.66M 121.55M
Normalized Net Operating Profit after Tax (NOPAT)
-28 -26 -60 -68 21 -79 -28
Normalized NOPAT Margin
-638.89% -125.26% -156.15% -173.76% 11.42% -131.87% -17.67%
Pre Tax Income Margin
-858.22% -176.09% -677.83% -268.49% 24.32% -179.63% 13.70%
Debt Service Ratios
- - - - - - -
EBIT to Interest Expense
-213.72 -125.05 -0.38 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
-149.60 -87.53 -0.32 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
-215.80 -132.80 -0.43 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-151.69 -95.28 -0.37 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for Immatics

No quarterly metrics and ratios for Immatics are available.


Frequently Asked Questions About Immatics' Financials

When does Immatics's financial year end?

According to the most recent income statement we have on file, Immatics' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Immatics' net income changed over the last 6 years?

Immatics' net income appears to be on a downward trend, with a most recent value of $15.75 million in 2024, falling from -$37.03 million in 2018. The previous period was -$104.70 million in 2023.

What is Immatics's operating income?
Immatics's total operating income in 2024 was -$39.97 million, based on the following breakdown:
  • Total Gross Profit: $161.30 million
  • Total Operating Expenses: $201.28 million
How has Immatics revenue changed over the last 6 years?

Over the last 6 years, Immatics' total revenue changed from $4.31 million in 2018 to $161.30 million in 2024, a change of 3,638.4%.

How much debt does Immatics have?

Immatics' total liabilities were at $123.77 million at the end of 2024, a 61.7% decrease from 2023, and a 37.0% decrease since 2019.

How much cash does Immatics have?

In the past 5 years, Immatics' cash and equivalents has ranged from $115.99 million in 2019 to $253.52 million in 2020, and is currently $245.06 million as of their latest financial filing in 2024.

How has Immatics' book value per share changed over the last 6 years?

Over the last 6 years, Immatics' book value per share changed from 0.00 in 2018 to -7.18 in 2024, a change of -718.1%.



This page (NASDAQ:IMTXW) was last updated on 4/21/2025 by MarketBeat.com Staff
From Our Partners